Abstract:Emerging studies have reported that coatomer protein complex subunit beta 2 (COPB2) is overexpressed in several types of malignant tumor; however, to the best of our knowledge, no studies regarding COPB2 in gastric cancer have been published thus far. Therefore, the present study aimed to determine the significance and function of COPB2 in gastric cancer. COPB2 expression in gastric cancer cell lines was measured using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) analysis. In addition, lentivirus-short hairpin RNA (shRNA) COPB2 (Lv-shCOPB2) was generated and used to infect BGC-823 cells to analyze the effects of COPB2 on the cancerous phenotype. The effects of shRNA-mediated COPB2 knockdown on cell proliferation were detected using MTT, 5-bromo-2-deoxyuridine and colony formation assays. In addition, the effects of COPB2 knockdown on apoptosis were analyzed by flow cytometry. Nude mice and fluorescence imaging were used to characterize the regulation of tumor growth in vivo, and qPCR and immunohistochemistry were subsequently conducted to analyze COPB2 expression in xenograft tumor tissues. Furthermore, a receptor tyrosine kinase (RTK) signaling pathway antibody array was used to explore the relevant molecular mechanisms underlying the effects of COPB2 knockdown. The results revealed that COPB2 mRNA was abundantly overexpressed in gastric cancer cell lines, whereas knockdown of COPB2 significantly inhibited cell growth and colony formation ability, and led to increased cell apoptosis in vitro. The tumorigenicity assay revealed that knockdown of COPB2 reduced tumor growth in nude mice, and fluorescence imaging indicated that the total radiant efficiency of mice in the Lv-shCOPB2-infected group was markedly reduced compared with the mice in the Lv-shRNA control-infected group in vivo. The antibody array assay revealed that the levels of phosphorylation in 23 target RTKs were significantly reduced: In conclusion, COPB2 was highly expressed in gastric cancer cell lines, and knockdown suppressed colony formation and promoted cell apoptosis via inhibiting the RTK signaling and its downstream signaling cascade molecules. Therefore, COPB2 may present a valuable target for gene silencing strategy in gastric cancer.

COPB2 Suppresses Cell Proliferation and Induces Cell Cycle Arrest in Human Colon Cancer by Regulating Cell Cycle-Related Proteins

COPB2 Gene Silencing Inhibits Colorectal Cancer Cell Proliferation and Induces Apoptosis Via the JNK/c-Jun Signaling Pathway

COPB2 is Upregulated in Prostate Cancer and Regulates PC-3 Cell Proliferation, Cell Cycle, and Apoptosis.

Silencing of COPB2 Inhibits the Proliferation of Gastric Cancer Cells and Induces Apoptosis Via Suppression of the RTK Signaling Pathway

Coatomer Subunit Beta 2 (COPB2), Identified by Label-Free Quantitative Proteomics, Regulates Cell Proliferation and Apoptosis in Human Prostate Carcinoma Cells.

Tpd52l2 Silencing Inhibits Lung Cancer Cell Proliferation By Cell Cycle G2/M Phase Arrest

Silencing the COPB2 Gene Decreases the Proliferation, Migration and Invasion of Human Triple-Negative Breast Cancer Cells

COPB2 Promotes Cell Proliferation and Tumorigenesis Through Up-Regulating YAP1 Expression in Lung Adenocarcinoma Cells.

High expression of COPB2 predicts adverse outcomes: A potential therapeutic target for glioma.

Suppression of cellular apoptosis susceptibility (CSE1L) inhibits proliferation and induces apoptosis in colorectal cancer cells.

Bone morphogenetic protein 2 inhibits the proliferation and growth of human colorectal cancer cells.

An Integrative Pan-Cancer Analysis of the Oncogenic Role of COPB2 in Human Tumors.

Upregulation of the Coatomer Protein Complex Subunit Beta 2 (COPB2) Gene Targets Microrna-335-3p in NCI-H1975 Lung Adenocarcinoma Cells to Promote Cell Proliferation and Migration.

Upregulation of COPB2 Promotes Prostate Cancer Proliferation and Invasion Through the MAPK/TGF-β Signaling Pathway

Coptisine from Rhizoma Coptidis Suppresses HCT-116 Cells-related Tumor Growth in Vitro and in Vivo

Coptisine-induced Apoptosis in Human Colon Cancer Cells (HCT-116) is Mediated by PI3K/Akt and Mitochondrial-Associated Apoptotic Pathway.

C-terminal Binding Protein-2 Promotes Cell Proliferation and Migration in Breast Cancer Via Suppression of P16ink4a

Coptisine inhibits the malignancy of bladder carcinoma cells and regulates XPO1 expression

Coptisine inhibits the proliferation of hepatocellular carcinoma by promoting ubiquitination of IGF2BP1

p27 inhibits CDK6/CCND1 complex formation resulting in cell cycle arrest and inhibition of cell proliferation

Downregulation of C-terminal-binding protein 2 inhibits human prostate cancer cell C4-2 proliferation and tumor growth in nude mice